1	(Tumo?r necrosis factor alpha adj2 antagonist).Mp. [mp = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]
2	(Tumo?r necrosis factor alpha adj2 antibody).Mp. [mp = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]
3	(Tumo?r necrosis factor alpha adj2 inhibitor).Mp. [mp = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]
4	Anti tumo?r necrosis factor.Mp.
5	Anti tumo?r necrosis factor alpha.Mp.
6	(anti TNF or anti‐TNF alpha).Mp. [mp = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]
7	Adalimumab.Mp.
8	Certolizumab pegol.Mp.
9	Etanercept.Mp.
10	Golimumab.Mp.
11	Infliximab.Mp.
12	1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11
13	Exp vascular stiffness/
14	Arterial stiffness.Mp.
15	Arterial function.Mp.
16	Arterial compliance.Mp.
17	Vascular function.Mp.
18	Vascular compliance.Mp.
19	Exp pulse wave analysis/
20	Pulse wave velocity.Mp.
21	Augmentation index.Mp.
22	Endothelial dysfunction.Mp.
23	Endothelial function.Mp.
24	Flow mediated dilation.Mp.
25	Flow mediated dilatation.Mp.
26	Exp carotid intima‐media thickness/
27	13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26
28	(chronic disease adj2 inflammat*).Mp. [mp = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]
29	Chronic inflammatory disease*.Mp.
30	Exp arthritis, rheumatoid/
31	Exp arthritis, psoriatic/
32	Exp spondylitis, ankylosing/
33	Exp inflammatory bowel diseases/or exp colitis, ulcerative/or exp crohn disease/
34	Exp enteritis/
35	Exp dermatitis/
36	Exp psoriasis/
37	Chronic inflammatory skin disease*.Mp.
38	Exp skin diseases, vesiculobullous/or exp pemphigoid, bullous/
39	Exp Vasculitis/
40	Exp lupus erythematosus, systemic/
41	Exp pulmonary disease, chronic obstructive/
42	Exp bronchitis, chronic/
43	28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42
44	12 and 27 and 43